about
Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein ArraysAntiviral antibody profiling by high-density protein arraysEnterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studiesCoxsackie viruses and diabetes mellitusMechanisms of Beta Cell Dysfunction Associated With Viral InfectionImmunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studiesVirus infections in type 1 diabetesEnvironmental risk factors for type 1 diabetesPotential viral pathogenic mechanism in human type 1 diabetesSaffold virus, an emerging human cardiovirus.Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.Viral antibody studies in pancreatic disease."Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.Environmental factors in the etiology of type 1 diabetes.Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.Role of viruses and other microbes in the pathogenesis of type 1 diabetes.Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations.Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM.Pathological changes in the pancreas of mice following infection with Coxsackie B virusesDiabetes mellitus-like syndrome in mice infected with encephalomyocarditis virusVirus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virusGenetic influences affecting the occurrence of a diabetes mellitus-like disease in mice infected with the encephalomyocarditis virusVirus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene.Genes mediating environment interactions in type 1 diabetes.Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic miceAltered immune regulation in type 1 diabetes.Enterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structureA Potential Link between Environmental Triggers and Autoimmunity.Viral infections in type 1 diabetes mellitus--why the β cells?Enteroviruses in the pathogenesis of type 1 diabetes.Immunopathology of the human pancreas in type-I diabetes.Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.Type 1 diabetes: etiology, immunology, and therapeutic strategies.Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.Enteroviruses and causality of type 1 diabetes: how close are we?Saffold virus, a novel human Cardiovirus with unknown pathogenicity.
P2860
Q21972778-C340E182-4718-4E9F-8EE2-422420CE16D7Q21972780-DF301668-B1DA-4801-97B7-40575023A0AAQ24630828-17420D55-EBBD-40EE-93F9-A9A45F041A59Q24673078-9924EC6D-D560-4C25-A2F3-AC67FA90BD25Q26797519-30B5A3BD-146A-4BCD-80D6-DC7D3120B6A9Q26862839-7D6614A7-BB40-4952-AB06-BB17E034B25BQ27000117-8642D268-CF81-4139-8295-E53D167D06FFQ28276366-23C8AC15-8804-45D5-8F11-6A8D4AF4FCA3Q28656023-50A7F1D8-DB49-4FF8-A047-38EEC1270BBAQ30244703-1449D690-B7A9-42A7-A830-A4F85F6FB2AEQ33577471-9A098AC9-B865-4A88-9064-B1EDD7E08365Q33803450-01054FB5-7FDF-47C0-9449-D368F619B36CQ34195258-2430A813-026D-4701-8BD0-DB4C3F119ACDQ34359584-15A6AA7F-C8E1-4951-9E78-9C5EDE071687Q34477248-7A83F6AE-5443-45B2-A80A-832A017B2A39Q34520218-AB8670D4-C086-4A34-A8F1-29345343ED05Q34737247-DCCB6B89-CD1C-4121-8943-B5901375EDB0Q34773751-28355CB1-416B-4DA0-9715-6B8BDDEE1FA7Q35115373-5B383BEB-D9EE-4DBF-B740-F96C295C42A3Q35835104-32D3363B-FE07-4B76-8F17-73EE17556320Q35948175-CBBEF563-8280-4F7B-8235-6705C48DD7A1Q36090498-D5886B1E-AEEA-4572-9C4D-7F046815E932Q36101499-C1BFA290-A168-4FA7-B28E-2640FCE50064Q36271875-3C62DAC9-C90F-497E-A10E-3D24B284A5B3Q36272942-F7C596D3-8772-4BDB-B1F3-9EA462D4DB5DQ36341943-5A66B214-9C2F-4201-BF24-FEFD0F1F9851Q36359358-050F34CD-EE0A-43E1-BEF7-C10EBD93E57AQ36816687-B0E22F4E-2510-4B72-BFBB-7E47DB2737DFQ37012246-D22DF372-C522-4CA8-BCEC-8FC68E3B5190Q37148578-07496A98-EA0B-49F0-910E-F62F0C8A4E06Q37177400-5AF2A328-B362-4C79-AE06-7BF3E34315B5Q37622097-5200B764-F3C7-45AD-B37F-60391891BA46Q37697741-511633DA-4664-46F1-819A-AC070AF675B4Q37737983-B051E7AC-5367-48E5-ADD3-FCE572E81F27Q37737985-3D5459AD-A73C-4134-834C-D127AA7355AFQ37744147-8E5F4154-8A30-438F-A87E-29C497D5F30EQ37830198-FB5DE50B-EFAC-46D0-9D0E-2ED480301925Q37877267-42C51558-E819-45E1-A55A-A4759181B35DQ37947366-338AA139-E50A-42E4-B094-B3BE2DCBD921Q37960473-4FF21653-8559-456E-928F-C765AE12256C
P2860
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Viral antibodies in diabetes mellitus.
@en
Viral antibodies in diabetes mellitus.
@nl
type
label
Viral antibodies in diabetes mellitus.
@en
Viral antibodies in diabetes mellitus.
@nl
prefLabel
Viral antibodies in diabetes mellitus.
@en
Viral antibodies in diabetes mellitus.
@nl
P2093
P2860
P356
P1433
P1476
Viral antibodies in diabetes mellitus.
@en
P2093
FitzGerald MG
Kinsley ML
P2860
P304
P356
10.1136/BMJ.3.5671.627
P407
P577
1969-09-01T00:00:00Z